[
  {
    "objectID": "quarto/index.html",
    "href": "quarto/index.html",
    "title": "Racial Disparities in Women Undergoing Coronary Artery Bypass Graft Surgery",
    "section": "",
    "text": "Study Objective: To investigate racial disparities in in-hospital outcomes among female patients undergoing coronary artery bypass graft (CABG) surgery.\nData Source: Cross-sectional analysis of the National Inpatient Sample (NIS) from 2018 to 2020.\nPopulation: Female inpatient admissions with CABG surgery as the principal procedure were included in the analysis.\nOutcomes:\n\nIn-hospital mortality\nCardiogenic shock\nMajor bleeding\nVenous thromboembolism\nAcute kidney injury\nTotal hospital charges\nLength of stay\n\nStatistical Analysis: Descriptive statistics for variables of interest are present as frequency and percentage of total admissions. Comparative statistics between patient groups was performed. Multiple logistic and linear regression was performed to identify variables independently associated with outcomes in women undergoing CABG surgery, respectively, adjusted for:\n\nDemographics: Age, sex, race, residential income, insurance, hospital region, hospital bedsize, hospital location, and teaching status.\nMedical History: Hypertension, diabetes mellitus, fluid/electrolytes imbalance, coronary artery disease, liver disease, peripheral vascular disease, heart failure, chronic kidney disease, chronic obstructive pulmonary disease, anemia, obesity, tobacco use disorde, prior PCI, prior stroke, prior MI, prior cardiac surgery.\nComorbidities: Charlson comorbidity index.\n\nSoftware: All analyses were performed using R Version 4.4.1 (R Foundation for Statistical Computing, Vienna, Austria)"
  },
  {
    "objectID": "quarto/index.html#preamble",
    "href": "quarto/index.html#preamble",
    "title": "Racial Disparities in Women Undergoing Coronary Artery Bypass Graft Surgery",
    "section": "",
    "text": "Study Objective: To investigate racial disparities in in-hospital outcomes among female patients undergoing coronary artery bypass graft (CABG) surgery.\nData Source: Cross-sectional analysis of the National Inpatient Sample (NIS) from 2018 to 2020.\nPopulation: Female inpatient admissions with CABG surgery as the principal procedure were included in the analysis.\nOutcomes:\n\nIn-hospital mortality\nCardiogenic shock\nMajor bleeding\nVenous thromboembolism\nAcute kidney injury\nTotal hospital charges\nLength of stay\n\nStatistical Analysis: Descriptive statistics for variables of interest are present as frequency and percentage of total admissions. Comparative statistics between patient groups was performed. Multiple logistic and linear regression was performed to identify variables independently associated with outcomes in women undergoing CABG surgery, respectively, adjusted for:\n\nDemographics: Age, sex, race, residential income, insurance, hospital region, hospital bedsize, hospital location, and teaching status.\nMedical History: Hypertension, diabetes mellitus, fluid/electrolytes imbalance, coronary artery disease, liver disease, peripheral vascular disease, heart failure, chronic kidney disease, chronic obstructive pulmonary disease, anemia, obesity, tobacco use disorde, prior PCI, prior stroke, prior MI, prior cardiac surgery.\nComorbidities: Charlson comorbidity index.\n\nSoftware: All analyses were performed using R Version 4.4.1 (R Foundation for Statistical Computing, Vienna, Austria)"
  },
  {
    "objectID": "quarto/index.html#descriptive-analysis",
    "href": "quarto/index.html#descriptive-analysis",
    "title": "Racial Disparities in Women Undergoing Coronary Artery Bypass Graft Surgery",
    "section": "Descriptive analysis",
    "text": "Descriptive analysis\n\nBaseline Characteristics:\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nCharacteristic\nWhite N = 101,2151\nOverall N = 136,1101\nAsian or Pacific Islander N = 4,1151\nBlack N = 15,4051\nHispanic N = 10,8951\nNative American N = 9401\nOther N = 3,5401\np-value2\n\n\n\n\nAge, y\n69 (61, 75)\n68 (60, 74)\n67 (60, 73)\n64 (57, 71)\n67 (58, 72)\n64 (57, 72)\n67 (60, 73)\n&lt;0.001\n\n\nResidential income\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n&lt;0.001\n\n\n    $1 - $51,999\n29,060 (29%)\n43,450 (32%)\n540 (13%)\n8,255 (54%)\n4,305 (40%)\n410 (46%)\n880 (25%)\n\n\n\n\n    $52,000 - $65,999\n30,010 (30%)\n38,250 (29%)\n820 (20%)\n3,370 (22%)\n2,895 (27%)\n235 (27%)\n920 (26%)\n\n\n\n\n    $66,000 - $87,999\n24,435 (25%)\n31,000 (23%)\n1,115 (27%)\n2,260 (15%)\n2,190 (20%)\n150 (17%)\n850 (24%)\n\n\n\n\n    $88,000 or more\n16,220 (16%)\n21,335 (16%)\n1,580 (39%)\n1,270 (8.4%)\n1,340 (12%)\n90 (10%)\n835 (24%)\n\n\n\n\nExpected primary payer\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n&lt;0.001\n\n\n    Private\n25,990 (26%)\n36,010 (26%)\n1,315 (32%)\n4,455 (29%)\n2,980 (27%)\n230 (24%)\n1,040 (29%)\n\n\n\n\n    Medicaid\n7,030 (7.0%)\n12,260 (9.0%)\n640 (16%)\n2,115 (14%)\n1,755 (16%)\n115 (12%)\n605 (17%)\n\n\n\n\n    Medicare\n66,590 (66%)\n85,620 (63%)\n2,050 (50%)\n8,560 (56%)\n6,015 (55%)\n550 (59%)\n1,855 (52%)\n\n\n\n\n    Other\n1,510 (1.5%)\n2,105 (1.5%)\n110 (2.7%)\n260 (1.7%)\n145 (1.3%)\n45 (4.8%)\n35 (1.0%)\n\n\n\n\nHospital region\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n&lt;0.001\n\n\n    Midwest\n26,145 (26%)\n30,760 (23%)\n465 (11%)\n2,805 (18%)\n740 (6.8%)\n210 (22%)\n395 (11%)\n\n\n\n\n    Northeast\n16,235 (16%)\n21,570 (16%)\n625 (15%)\n1,995 (13%)\n1,610 (15%)\n45 (4.8%)\n1,060 (30%)\n\n\n\n\n    South\n45,515 (45%)\n62,790 (46%)\n825 (20%)\n9,695 (63%)\n5,000 (46%)\n375 (40%)\n1,380 (39%)\n\n\n\n\n    West\n13,320 (13%)\n20,990 (15%)\n2,200 (53%)\n910 (5.9%)\n3,545 (33%)\n310 (33%)\n705 (20%)\n\n\n\n\nHospital bedsize\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n0.038\n\n\n    Large\n61,440 (61%)\n83,130 (61%)\n2,685 (65%)\n9,630 (63%)\n6,665 (61%)\n490 (52%)\n2,220 (63%)\n\n\n\n\n    Medium\n26,990 (27%)\n36,405 (27%)\n1,060 (26%)\n4,165 (27%)\n3,005 (28%)\n240 (26%)\n945 (27%)\n\n\n\n\n    Small\n12,785 (13%)\n16,575 (12%)\n370 (9.0%)\n1,610 (10%)\n1,225 (11%)\n210 (22%)\n375 (11%)\n\n\n\n\nHospital location and teaching status\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n&lt;0.001\n\n\n    Rural\n3,370 (3.3%)\n3,895 (2.9%)\n10 (0.2%)\n395 (2.6%)\n45 (0.4%)\n70 (7.4%)\n5 (0.1%)\n\n\n\n\n    Urban, non-teaching\n13,750 (14%)\n18,230 (13%)\n600 (15%)\n1,655 (11%)\n1,660 (15%)\n130 (14%)\n435 (12%)\n\n\n\n\n    Urban, teaching\n84,095 (83%)\n113,985 (84%)\n3,505 (85%)\n13,355 (87%)\n9,190 (84%)\n740 (79%)\n3,100 (88%)\n\n\n\n\nHypertension\n89,055 (88%)\n121,370 (89%)\n3,810 (93%)\n14,300 (93%)\n10,090 (93%)\n875 (93%)\n3,240 (92%)\n&lt;0.001\n\n\nDiabetes mellitus\n50,470 (50%)\n73,905 (54%)\n2,815 (68%)\n9,770 (63%)\n7,970 (73%)\n635 (68%)\n2,245 (63%)\n&lt;0.001\n\n\nFluid/electrolytes imbalance\n41,755 (41%)\n57,260 (42%)\n1,980 (48%)\n6,785 (44%)\n4,775 (44%)\n415 (44%)\n1,550 (44%)\n&lt;0.001\n\n\nLiver disease\n4,685 (4.6%)\n6,450 (4.7%)\n240 (5.8%)\n720 (4.7%)\n525 (4.8%)\n40 (4.3%)\n240 (6.8%)\n0.10\n\n\nCoronary artery disease\n96,970 (96%)\n130,375 (96%)\n4,005 (97%)\n14,695 (95%)\n10,440 (96%)\n895 (95%)\n3,370 (95%)\n0.3\n\n\nPeripheral vascular disease\n15,740 (16%)\n20,540 (15%)\n615 (15%)\n2,100 (14%)\n1,425 (13%)\n165 (18%)\n495 (14%)\n0.012\n\n\nHeart failure\n40,585 (40%)\n56,975 (42%)\n1,790 (43%)\n7,575 (49%)\n4,965 (46%)\n430 (46%)\n1,630 (46%)\n&lt;0.001\n\n\nChronic kidney disease\n20,170 (20%)\n30,290 (22%)\n1,145 (28%)\n4,860 (32%)\n3,050 (28%)\n280 (30%)\n785 (22%)\n&lt;0.001\n\n\nChronic obstructive pulmonary disease\n29,305 (29%)\n37,250 (27%)\n580 (14%)\n4,075 (26%)\n2,300 (21%)\n225 (24%)\n765 (22%)\n&lt;0.001\n\n\nAnemia\n4,390 (4.3%)\n6,495 (4.8%)\n230 (5.6%)\n945 (6.1%)\n665 (6.1%)\n75 (8.0%)\n190 (5.4%)\n&lt;0.001\n\n\nObesity\n35,285 (35%)\n47,355 (35%)\n715 (17%)\n6,060 (39%)\n3,850 (35%)\n320 (34%)\n1,125 (32%)\n&lt;0.001\n\n\nTobbacco use disorder\n820 (0.8%)\n1,085 (0.8%)\n10 (0.2%)\n150 (1.0%)\n95 (0.9%)\n0 (0%)\n10 (0.3%)\n0.2\n\n\nPrior PCI\n13,920 (14%)\n18,590 (14%)\n360 (8.7%)\n2,365 (15%)\n1,415 (13%)\n160 (17%)\n370 (10%)\n&lt;0.001\n\n\nPrior myocardial inafarction\n16,580 (16%)\n22,455 (16%)\n610 (15%)\n2,730 (18%)\n1,930 (18%)\n165 (18%)\n440 (12%)\n0.010\n\n\nPrior stroke\n9,850 (9.7%)\n13,895 (10%)\n425 (10%)\n2,070 (13%)\n1,145 (11%)\n120 (13%)\n285 (8.1%)\n&lt;0.001\n\n\nPrior cardiac surgery\n3,230 (3.2%)\n4,265 (3.1%)\n80 (1.9%)\n440 (2.9%)\n405 (3.7%)\n15 (1.6%)\n95 (2.7%)\n0.11\n\n\nCharlson comorbidity index\n2.00 (1.00, 4.00)\n3.00 (1.00, 4.00)\n3.00 (1.00, 5.00)\n3.00 (2.00, 5.00)\n3.00 (2.00, 5.00)\n3.00 (2.00, 5.00)\n3.00 (2.00, 4.00)\n&lt;0.001\n\n\n\n1 Median (Q1, Q3); n (%)\n\n\n2 Design-based KruskalWallis test; Pearson’s X^2: Rao & Scott adjustment\n\n\n\n\n\n\n\n\n\n\nOutcomes Table:\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nCharacteristic\nWhite N = 101,2151\nOverall N = 136,1101\nAsian or Pacific Islander N = 4,1151\nBlack N = 15,4051\nHispanic N = 10,8951\nNative American N = 9401\nOther N = 3,5401\np-value2\n\n\n\n\nDied during hospitalization\n3,720 (3.7%)\n5,235 (3.8%)\n175 (4.3%)\n695 (4.5%)\n470 (4.3%)\n55 (5.9%)\n120 (3.4%)\n0.10\n\n\nLength of stay (days)\n9 (6, 12)\n9 (6, 13)\n9 (6, 13)\n10 (7, 15)\n10 (7, 13)\n9 (6, 12)\n10 (7, 14)\n&lt;0.001\n\n\nInflation-adjusted total charge ($)\n189,014 (131,780, 288,174)\n199,525 (137,404, 308,242)\n254,881 (166,781, 399,227)\n209,884 (146,881, 328,386)\n265,084 (181,392, 400,569)\n171,448 (123,669, 277,475)\n246,181 (166,553, 384,068)\n&lt;0.001\n\n\nMajor bleeding\n7,570 (7.5%)\n10,700 (7.9%)\n310 (7.5%)\n1,435 (9.3%)\n960 (8.8%)\n70 (7.4%)\n355 (10%)\n0.001\n\n\nAcute ischemic stroke\n4,875 (4.8%)\n7,550 (5.5%)\n250 (6.1%)\n1,380 (9.0%)\n805 (7.4%)\n45 (4.8%)\n195 (5.5%)\n&lt;0.001\n\n\nAcute kidney failure\n21,795 (22%)\n31,400 (23%)\n1,030 (25%)\n4,520 (29%)\n2,925 (27%)\n215 (23%)\n915 (26%)\n&lt;0.001\n\n\nCardiogenic shock\n9,020 (8.9%)\n12,930 (9.5%)\n435 (11%)\n1,625 (11%)\n1,295 (12%)\n110 (12%)\n445 (13%)\n&lt;0.001\n\n\nVenous thromboembolism\n1,820 (1.8%)\n2,695 (2.0%)\n60 (1.5%)\n440 (2.9%)\n235 (2.2%)\n20 (2.1%)\n120 (3.4%)\n&lt;0.001\n\n\n\n1 n (%); Median (Q1, Q3)\n\n\n2 Pearson’s X^2: Rao & Scott adjustment; Design-based KruskalWallis test"
  },
  {
    "objectID": "quarto/index.html#multivariable-logistic-regression",
    "href": "quarto/index.html#multivariable-logistic-regression",
    "title": "Racial Disparities in Women Undergoing Coronary Artery Bypass Graft Surgery",
    "section": "Multivariable Logistic Regression:",
    "text": "Multivariable Logistic Regression:\n\nIn-hospital mortality:\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nCharacteristic\nOR1\n95% CI1\np-value\n\n\n\n\nRace\n\n\n\n\n\n\n\n\n    White\n—\n—\n\n\n\n\n    Asian or Pacific Islander\n1.11\n0.77, 1.60\n0.6\n\n\n    Black\n1.41\n1.14, 1.75\n0.002\n\n\n    Hispanic\n1.32\n1.02, 1.70\n0.034\n\n\n    Native American\n1.84\n0.97, 3.48\n0.062\n\n\n    Other\n0.85\n0.55, 1.32\n0.5\n\n\nAge, y\n1.03\n1.02, 1.05\n&lt;0.001\n\n\nResidential income\n\n\n\n\n\n\n\n\n    $1 - $51,999\n—\n—\n\n\n\n\n    $52,000 - $65,999\n0.97\n0.81, 1.16\n0.7\n\n\n    $66,000 - $87,999\n0.90\n0.75, 1.09\n0.3\n\n\n    $88,000 or more\n0.88\n0.71, 1.09\n0.2\n\n\nExpected primary payer\n\n\n\n\n\n\n\n\n    Private\n—\n—\n\n\n\n\n    Medicaid\n1.39\n1.02, 1.91\n0.039\n\n\n    Medicare\n1.44\n1.16, 1.80\n0.001\n\n\n    Other\n2.00\n1.21, 3.30\n0.007\n\n\nHospital region\n\n\n\n\n\n\n\n\n    Midwest\n—\n—\n\n\n\n\n    Northeast\n1.21\n0.86, 1.71\n0.3\n\n\n    South\n1.16\n0.89, 1.52\n0.3\n\n\n    West\n1.36\n1.03, 1.78\n0.028\n\n\nHOSP_DIVISION\n\n\n\n\n\n\n\n\n    East North Central\n—\n—\n\n\n\n\n    East South Central\n1.10\n0.82, 1.49\n0.5\n\n\n    Middle Atlantic\n0.99\n0.69, 1.43\n&gt;0.9\n\n\n    Mountain\n0.71\n0.49, 1.04\n0.078\n\n\n    South Atlantic\n0.84\n0.65, 1.09\n0.2\n\n\n    West North Central\n1.21\n0.89, 1.66\n0.2\n\n\nHospital bedsize\n\n\n\n\n\n\n\n\n    Large\n—\n—\n\n\n\n\n    Medium\n1.10\n0.93, 1.31\n0.3\n\n\n    Small\n1.31\n1.04, 1.65\n0.020\n\n\nHospital location and teaching status\n\n\n\n\n\n\n\n\n    Rural\n—\n—\n\n\n\n\n    Urban, non-teaching\n0.73\n0.47, 1.12\n0.2\n\n\n    Urban, teaching\n0.60\n0.40, 0.90\n0.014\n\n\nHypertension\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.66\n0.54, 0.81\n&lt;0.001\n\n\nDiabetes mellitus\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.68\n0.57, 0.80\n&lt;0.001\n\n\nCoronary artery disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.22\n0.18, 0.27\n&lt;0.001\n\n\nHeart failure\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.97\n1.67, 2.32\n&lt;0.001\n\n\nChronic kidney disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.17\n0.95, 1.44\n0.14\n\n\nChronic obstructive pulmonary disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.96\n0.81, 1.14\n0.7\n\n\nPeripheral vascular disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.60\n1.34, 1.91\n&lt;0.001\n\n\nLiver disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n5.36\n4.47, 6.42\n&lt;0.001\n\n\nFluid/electrolytes imbalance\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n2.67\n2.30, 3.09\n&lt;0.001\n\n\nAnemia\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.80\n0.59, 1.09\n0.2\n\n\nObesity\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.81\n0.69, 0.95\n0.008\n\n\nTobbacco use disorder\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.48\n0.16, 1.47\n0.2\n\n\nPrior PCI\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.93\n0.73, 1.19\n0.6\n\n\nPrior myocardial inafarction\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.67\n0.53, 0.84\n&lt;0.001\n\n\nPrior stroke\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.77\n0.60, 0.99\n0.041\n\n\nPrior cardiac surgery\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.75\n1.26, 2.43\n&lt;0.001\n\n\nCharlson comorbidity index\n1.06\n1.00, 1.13\n0.054\n\n\n\n1 OR = Odds Ratio, CI = Confidence Interval\n\n\n\n\n\n\n\n\n\n\nMajor bleeding:\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nCharacteristic\nOR1\n95% CI1\np-value\n\n\n\n\nRace\n\n\n\n\n\n\n\n\n    White\n—\n—\n\n\n\n\n    Asian or Pacific Islander\n0.96\n0.71, 1.30\n0.8\n\n\n    Black\n1.16\n1.00, 1.34\n0.054\n\n\n    Hispanic\n1.23\n1.03, 1.46\n0.023\n\n\n    Native American\n1.05\n0.61, 1.82\n0.9\n\n\n    Other\n1.48\n1.15, 1.90\n0.003\n\n\nAge, y\n1.00\n1.00, 1.01\n0.12\n\n\nResidential income\n\n\n\n\n\n\n\n\n    $1 - $51,999\n—\n—\n\n\n\n\n    $52,000 - $65,999\n1.06\n0.94, 1.20\n0.3\n\n\n    $66,000 - $87,999\n1.07\n0.94, 1.23\n0.3\n\n\n    $88,000 or more\n1.16\n0.99, 1.35\n0.064\n\n\nExpected primary payer\n\n\n\n\n\n\n\n\n    Private\n—\n—\n\n\n\n\n    Medicaid\n1.14\n0.94, 1.39\n0.2\n\n\n    Medicare\n1.40\n1.22, 1.60\n&lt;0.001\n\n\n    Other\n1.11\n0.73, 1.66\n0.6\n\n\nHospital region\n\n\n\n\n\n\n\n\n    Midwest\n—\n—\n\n\n\n\n    Northeast\n0.91\n0.68, 1.20\n0.5\n\n\n    South\n0.83\n0.69, 0.99\n0.042\n\n\n    West\n0.84\n0.68, 1.03\n0.089\n\n\nHOSP_DIVISION\n\n\n\n\n\n\n\n\n    East North Central\n—\n—\n\n\n\n\n    East South Central\n1.05\n0.84, 1.30\n0.7\n\n\n    Middle Atlantic\n1.00\n0.75, 1.33\n&gt;0.9\n\n\n    Mountain\n0.97\n0.71, 1.34\n0.9\n\n\n    South Atlantic\n1.17\n0.98, 1.38\n0.082\n\n\n    West North Central\n0.76\n0.60, 0.97\n0.028\n\n\nHospital bedsize\n\n\n\n\n\n\n\n\n    Large\n—\n—\n\n\n\n\n    Medium\n0.98\n0.88, 1.10\n0.8\n\n\n    Small\n0.78\n0.65, 0.94\n0.008\n\n\nHospital location and teaching status\n\n\n\n\n\n\n\n\n    Rural\n—\n—\n\n\n\n\n    Urban, non-teaching\n0.83\n0.60, 1.15\n0.3\n\n\n    Urban, teaching\n0.96\n0.71, 1.29\n0.8\n\n\nHypertension\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.97\n0.82, 1.14\n0.7\n\n\nDiabetes mellitus\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.45\n0.39, 0.50\n&lt;0.001\n\n\nCoronary artery disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.59\n0.49, 0.72\n&lt;0.001\n\n\nHeart failure\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.71\n0.63, 0.79\n&lt;0.001\n\n\nChronic kidney disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.41\n0.35, 0.47\n&lt;0.001\n\n\nChronic obstructive pulmonary disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.66\n0.59, 0.74\n&lt;0.001\n\n\nPeripheral vascular disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.61\n0.54, 0.70\n&lt;0.001\n\n\nLiver disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.47\n1.24, 1.74\n&lt;0.001\n\n\nFluid/electrolytes imbalance\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.20\n1.09, 1.32\n&lt;0.001\n\n\nAnemia\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.89\n1.58, 2.26\n&lt;0.001\n\n\nObesity\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.91\n0.81, 1.01\n0.068\n\n\nTobbacco use disorder\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.94\n0.56, 1.58\n0.8\n\n\nPrior PCI\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.82\n0.70, 0.95\n0.010\n\n\nPrior myocardial inafarction\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.80\n0.70, 0.91\n&lt;0.001\n\n\nPrior stroke\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n5.19\n4.67, 5.76\n&lt;0.001\n\n\nPrior cardiac surgery\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.90\n0.69, 1.19\n0.5\n\n\nCharlson comorbidity index\n1.56\n1.50, 1.63\n&lt;0.001\n\n\n\n1 OR = Odds Ratio, CI = Confidence Interval\n\n\n\n\n\n\n\n\n\n\nAcute ischemic stroke:\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nCharacteristic\nOR1\n95% CI1\np-value\n\n\n\n\nRace\n\n\n\n\n\n\n\n\n    White\n—\n—\n\n\n\n\n    Asian or Pacific Islander\n1.15\n0.84, 1.57\n0.4\n\n\n    Black\n1.62\n1.40, 1.88\n&lt;0.001\n\n\n    Hispanic\n1.36\n1.12, 1.65\n0.002\n\n\n    Native American\n0.76\n0.37, 1.57\n0.5\n\n\n    Other\n1.04\n0.74, 1.45\n0.8\n\n\nAge, y\n0.99\n0.99, 1.00\n0.037\n\n\nResidential income\n\n\n\n\n\n\n\n\n    $1 - $51,999\n—\n—\n\n\n\n\n    $52,000 - $65,999\n0.96\n0.84, 1.11\n0.6\n\n\n    $66,000 - $87,999\n0.99\n0.85, 1.15\n&gt;0.9\n\n\n    $88,000 or more\n1.02\n0.85, 1.21\n0.8\n\n\nExpected primary payer\n\n\n\n\n\n\n\n\n    Private\n—\n—\n\n\n\n\n    Medicaid\n1.34\n1.10, 1.62\n0.003\n\n\n    Medicare\n1.03\n0.89, 1.19\n0.7\n\n\n    Other\n0.62\n0.36, 1.07\n0.089\n\n\nHospital region\n\n\n\n\n\n\n\n\n    Midwest\n—\n—\n\n\n\n\n    Northeast\n0.76\n0.55, 1.06\n0.11\n\n\n    South\n1.12\n0.92, 1.36\n0.3\n\n\n    West\n0.87\n0.70, 1.08\n0.2\n\n\nHOSP_DIVISION\n\n\n\n\n\n\n\n\n    East North Central\n—\n—\n\n\n\n\n    East South Central\n0.68\n0.52, 0.89\n0.004\n\n\n    Middle Atlantic\n1.07\n0.76, 1.51\n0.7\n\n\n    Mountain\n1.11\n0.83, 1.49\n0.5\n\n\n    South Atlantic\n0.87\n0.72, 1.05\n0.14\n\n\n    West North Central\n0.95\n0.74, 1.22\n0.7\n\n\nHospital bedsize\n\n\n\n\n\n\n\n\n    Large\n—\n—\n\n\n\n\n    Medium\n1.13\n1.00, 1.29\n0.051\n\n\n    Small\n1.06\n0.87, 1.28\n0.6\n\n\nHospital location and teaching status\n\n\n\n\n\n\n\n\n    Rural\n—\n—\n\n\n\n\n    Urban, non-teaching\n0.99\n0.62, 1.58\n&gt;0.9\n\n\n    Urban, teaching\n1.22\n0.79, 1.90\n0.4\n\n\nHypertension\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.61\n1.30, 2.01\n&lt;0.001\n\n\nDiabetes mellitus\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.68\n0.60, 0.78\n&lt;0.001\n\n\nCoronary artery disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.90\n0.70, 1.15\n0.4\n\n\nHeart failure\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.14\n1.01, 1.29\n0.036\n\n\nChronic kidney disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.69\n0.59, 0.81\n&lt;0.001\n\n\nChronic obstructive pulmonary disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.70\n0.62, 0.80\n&lt;0.001\n\n\nPeripheral vascular disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.96\n0.82, 1.11\n0.6\n\n\nLiver disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.87\n0.68, 1.10\n0.2\n\n\nFluid/electrolytes imbalance\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.23\n1.10, 1.38\n&lt;0.001\n\n\nAnemia\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.27\n1.02, 1.58\n0.030\n\n\nObesity\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.22\n1.09, 1.36\n&lt;0.001\n\n\nTobbacco use disorder\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.76\n0.40, 1.45\n0.4\n\n\nPrior PCI\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.69\n0.57, 0.83\n&lt;0.001\n\n\nPrior myocardial inafarction\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.76\n0.65, 0.90\n0.001\n\n\nPrior stroke\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.86\n0.72, 1.04\n0.11\n\n\nPrior cardiac surgery\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.86\n0.62, 1.20\n0.4\n\n\nCharlson comorbidity index\n1.29\n1.24, 1.35\n&lt;0.001\n\n\n\n1 OR = Odds Ratio, CI = Confidence Interval\n\n\n\n\n\n\n\n\n\n\nCardiogenic shock:\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nCharacteristic\nOR1\n95% CI1\np-value\n\n\n\n\nRace\n\n\n\n\n\n\n\n\n    White\n—\n—\n\n\n\n\n    Asian or Pacific Islander\n0.99\n0.78, 1.27\n&gt;0.9\n\n\n    Black\n1.16\n1.01, 1.34\n0.033\n\n\n    Hispanic\n1.23\n1.04, 1.45\n0.017\n\n\n    Native American\n1.18\n0.72, 1.92\n0.5\n\n\n    Other\n1.36\n1.05, 1.76\n0.020\n\n\nAge, y\n1.01\n1.00, 1.01\n0.004\n\n\nResidential income\n\n\n\n\n\n\n\n\n    $1 - $51,999\n—\n—\n\n\n\n\n    $52,000 - $65,999\n1.01\n0.90, 1.13\n0.9\n\n\n    $66,000 - $87,999\n0.92\n0.81, 1.05\n0.2\n\n\n    $88,000 or more\n1.18\n1.03, 1.36\n0.020\n\n\nExpected primary payer\n\n\n\n\n\n\n\n\n    Private\n—\n—\n\n\n\n\n    Medicaid\n1.04\n0.88, 1.24\n0.6\n\n\n    Medicare\n0.94\n0.83, 1.06\n0.3\n\n\n    Other\n1.04\n0.73, 1.47\n0.8\n\n\nHospital region\n\n\n\n\n\n\n\n\n    Midwest\n—\n—\n\n\n\n\n    Northeast\n1.07\n0.81, 1.40\n0.6\n\n\n    South\n1.47\n1.19, 1.80\n&lt;0.001\n\n\n    West\n1.12\n0.91, 1.39\n0.3\n\n\nHOSP_DIVISION\n\n\n\n\n\n\n\n\n    East North Central\n—\n—\n\n\n\n\n    East South Central\n0.50\n0.40, 0.64\n&lt;0.001\n\n\n    Middle Atlantic\n0.66\n0.50, 0.87\n0.003\n\n\n    Mountain\n0.98\n0.76, 1.26\n0.9\n\n\n    South Atlantic\n0.62\n0.51, 0.75\n&lt;0.001\n\n\n    West North Central\n1.07\n0.81, 1.41\n0.6\n\n\nHospital bedsize\n\n\n\n\n\n\n\n\n    Large\n—\n—\n\n\n\n\n    Medium\n0.83\n0.73, 0.95\n0.005\n\n\n    Small\n0.76\n0.63, 0.93\n0.007\n\n\nHospital location and teaching status\n\n\n\n\n\n\n\n\n    Rural\n—\n—\n\n\n\n\n    Urban, non-teaching\n1.33\n0.91, 1.96\n0.14\n\n\n    Urban, teaching\n1.61\n1.12, 2.30\n0.010\n\n\nHypertension\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.64\n0.56, 0.73\n&lt;0.001\n\n\nDiabetes mellitus\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.72\n0.64, 0.81\n&lt;0.001\n\n\nCoronary artery disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.44\n0.38, 0.52\n&lt;0.001\n\n\nHeart failure\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n2.84\n2.55, 3.16\n&lt;0.001\n\n\nChronic kidney disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.73\n0.63, 0.84\n&lt;0.001\n\n\nChronic obstructive pulmonary disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.84\n0.75, 0.94\n0.003\n\n\nPeripheral vascular disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.09\n0.97, 1.24\n0.2\n\n\nLiver disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n2.14\n1.84, 2.48\n&lt;0.001\n\n\nFluid/electrolytes imbalance\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n2.13\n1.93, 2.35\n&lt;0.001\n\n\nAnemia\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.97\n0.80, 1.17\n0.7\n\n\nObesity\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.86\n0.78, 0.94\n0.001\n\n\nTobbacco use disorder\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.81\n0.45, 1.45\n0.5\n\n\nPrior PCI\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.86\n0.74, 1.00\n0.057\n\n\nPrior myocardial inafarction\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.68\n0.59, 0.78\n&lt;0.001\n\n\nPrior stroke\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.71\n0.60, 0.84\n&lt;0.001\n\n\nPrior cardiac surgery\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.25\n0.98, 1.58\n0.069\n\n\nCharlson comorbidity index\n1.15\n1.10, 1.20\n&lt;0.001\n\n\n\n1 OR = Odds Ratio, CI = Confidence Interval\n\n\n\n\n\n\n\n\n\n\nVenous thromboembolism:\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nCharacteristic\nOR1\n95% CI1\np-value\n\n\n\n\nRace\n\n\n\n\n\n\n\n\n    White\n—\n—\n\n\n\n\n    Asian or Pacific Islander\n0.70\n0.39, 1.24\n0.2\n\n\n    Black\n1.41\n1.10, 1.79\n0.006\n\n\n    Hispanic\n1.15\n0.82, 1.60\n0.4\n\n\n    Native American\n1.17\n0.44, 3.15\n0.8\n\n\n    Other\n1.85\n1.19, 2.86\n0.006\n\n\nAge, y\n1.00\n0.99, 1.01\n0.8\n\n\nResidential income\n\n\n\n\n\n\n\n\n    $1 - $51,999\n—\n—\n\n\n\n\n    $52,000 - $65,999\n0.89\n0.71, 1.13\n0.3\n\n\n    $66,000 - $87,999\n1.01\n0.79, 1.29\n&gt;0.9\n\n\n    $88,000 or more\n1.12\n0.85, 1.48\n0.4\n\n\nExpected primary payer\n\n\n\n\n\n\n\n\n    Private\n—\n—\n\n\n\n\n    Medicaid\n1.09\n0.76, 1.57\n0.6\n\n\n    Medicare\n1.18\n0.90, 1.55\n0.2\n\n\n    Other\n1.22\n0.60, 2.51\n0.6\n\n\nHospital region\n\n\n\n\n\n\n\n\n    Midwest\n—\n—\n\n\n\n\n    Northeast\n0.72\n0.40, 1.29\n0.3\n\n\n    South\n1.10\n0.80, 1.52\n0.5\n\n\n    West\n1.02\n0.71, 1.46\n&gt;0.9\n\n\nHOSP_DIVISION\n\n\n\n\n\n\n\n\n    East North Central\n—\n—\n\n\n\n\n    East South Central\n0.71\n0.46, 1.09\n0.12\n\n\n    Middle Atlantic\n1.04\n0.57, 1.91\n0.9\n\n\n    Mountain\n1.21\n0.75, 1.93\n0.4\n\n\n    South Atlantic\n0.98\n0.73, 1.32\n0.9\n\n\n    West North Central\n1.09\n0.74, 1.61\n0.7\n\n\nHospital bedsize\n\n\n\n\n\n\n\n\n    Large\n—\n—\n\n\n\n\n    Medium\n0.76\n0.61, 0.94\n0.014\n\n\n    Small\n0.63\n0.46, 0.86\n0.004\n\n\nHospital location and teaching status\n\n\n\n\n\n\n\n\n    Rural\n—\n—\n\n\n\n\n    Urban, non-teaching\n1.21\n0.57, 2.56\n0.6\n\n\n    Urban, teaching\n1.47\n0.72, 3.00\n0.3\n\n\nHypertension\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.66\n0.51, 0.85\n0.002\n\n\nDiabetes mellitus\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.67\n0.54, 0.84\n&lt;0.001\n\n\nCoronary artery disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.41\n0.31, 0.54\n&lt;0.001\n\n\nHeart failure\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.69\n1.37, 2.08\n&lt;0.001\n\n\nChronic kidney disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.13\n0.84, 1.51\n0.4\n\n\nChronic obstructive pulmonary disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.88\n0.72, 1.09\n0.2\n\n\nPeripheral vascular disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.00\n0.78, 1.27\n&gt;0.9\n\n\nLiver disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.42\n1.05, 1.91\n0.021\n\n\nFluid/electrolytes imbalance\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.96\n1.63, 2.37\n&lt;0.001\n\n\nAnemia\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.92\n0.62, 1.36\n0.7\n\n\nObesity\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.84\n0.69, 1.03\n0.093\n\n\nTobbacco use disorder\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.77\n0.77, 4.11\n0.2\n\n\nPrior PCI\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.72\n0.52, 0.99\n0.043\n\n\nPrior myocardial inafarction\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.79\n0.60, 1.03\n0.083\n\n\nPrior stroke\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.03\n0.78, 1.36\n0.9\n\n\nPrior cardiac surgery\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.44\n0.21, 0.94\n0.033\n\n\nCharlson comorbidity index\n1.15\n1.06, 1.25\n&lt;0.001\n\n\n\n1 OR = Odds Ratio, CI = Confidence Interval"
  },
  {
    "objectID": "quarto/index.html#multivariable-linear-regression",
    "href": "quarto/index.html#multivariable-linear-regression",
    "title": "Racial Disparities in Women Undergoing Coronary Artery Bypass Graft Surgery",
    "section": "Multivariable Linear Regression:",
    "text": "Multivariable Linear Regression:\n\nLength of stay:\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nCharacteristic\nBeta\n95% CI1\np-value\n\n\n\n\nRace\n\n\n\n\n\n\n\n\n    White\n—\n—\n\n\n\n\n    Asian or Pacific Islander\n0.83\n0.23, 1.4\n0.007\n\n\n    Black\n1.6\n1.2, 2.0\n&lt;0.001\n\n\n    Hispanic\n0.60\n0.20, 1.0\n0.003\n\n\n    Native American\n-0.46\n-1.6, 0.68\n0.4\n\n\n    Other\n0.54\n-0.05, 1.1\n0.072\n\n\nAge, y\n0.04\n0.03, 0.06\n&lt;0.001\n\n\nResidential income\n\n\n\n\n\n\n\n\n    $1 - $51,999\n—\n—\n\n\n\n\n    $52,000 - $65,999\n-0.04\n-0.29, 0.21\n0.8\n\n\n    $66,000 - $87,999\n-0.09\n-0.39, 0.22\n0.6\n\n\n    $88,000 or more\n-0.34\n-0.68, -0.01\n0.047\n\n\nExpected primary payer\n\n\n\n\n\n\n\n\n    Private\n—\n—\n\n\n\n\n    Medicaid\n1.6\n1.0, 2.1\n&lt;0.001\n\n\n    Medicare\n0.07\n-0.21, 0.34\n0.6\n\n\n    Other\n0.00\n-0.63, 0.63\n&gt;0.9\n\n\nHospital region\n\n\n\n\n\n\n\n\n    Midwest\n—\n—\n\n\n\n\n    Northeast\n0.73\n0.11, 1.3\n0.021\n\n\n    South\n0.38\n0.00, 0.75\n0.052\n\n\n    West\n0.00\n-0.43, 0.42\n&gt;0.9\n\n\nHOSP_DIVISION\n\n\n\n\n\n\n\n\n    East North Central\n—\n—\n\n\n\n\n    East South Central\n-0.07\n-0.57, 0.42\n0.8\n\n\n    Middle Atlantic\n-0.30\n-1.0, 0.41\n0.4\n\n\n    Mountain\n0.04\n-0.53, 0.62\n0.9\n\n\n    South Atlantic\n0.30\n-0.11, 0.71\n0.2\n\n\n    West North Central\n-0.26\n-0.74, 0.22\n0.3\n\n\nHospital bedsize\n\n\n\n\n\n\n\n\n    Large\n—\n—\n\n\n\n\n    Medium\n-0.46\n-0.73, -0.18\n0.001\n\n\n    Small\n-0.75\n-1.1, -0.42\n&lt;0.001\n\n\nHospital location and teaching status\n\n\n\n\n\n\n\n\n    Rural\n—\n—\n\n\n\n\n    Urban, non-teaching\n0.33\n-0.28, 0.94\n0.3\n\n\n    Urban, teaching\n0.88\n0.30, 1.5\n0.003\n\n\nHypertension\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n-1.4\n-1.8, -0.94\n&lt;0.001\n\n\nDiabetes mellitus\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n-1.6\n-1.9, -1.3\n&lt;0.001\n\n\nCoronary artery disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n-6.6\n-7.8, -5.5\n&lt;0.001\n\n\nHeart failure\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n2.0\n1.7, 2.2\n&lt;0.001\n\n\nChronic kidney disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n-0.69\n-1.2, -0.20\n0.006\n\n\nChronic obstructive pulmonary disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n-0.70\n-1.0, -0.39\n&lt;0.001\n\n\nPeripheral vascular disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n-1.1\n-1.4, -0.72\n&lt;0.001\n\n\nLiver disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.8\n1.1, 2.5\n&lt;0.001\n\n\nFluid/electrolytes imbalance\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n2.6\n2.4, 2.8\n&lt;0.001\n\n\nAnemia\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.0\n0.54, 1.5\n&lt;0.001\n\n\nObesity\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n-0.26\n-0.45, -0.07\n0.008\n\n\nTobbacco use disorder\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n-0.72\n-1.5, 0.03\n0.061\n\n\nPrior PCI\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n-0.23\n-0.47, 0.01\n0.064\n\n\nPrior myocardial inafarction\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n-1.7\n-1.9, -1.4\n&lt;0.001\n\n\nPrior stroke\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n-0.32\n-0.60, -0.04\n0.024\n\n\nPrior cardiac surgery\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n-0.42\n-0.92, 0.07\n0.092\n\n\nCharlson comorbidity index\n1.2\n0.99, 1.3\n&lt;0.001\n\n\n\n1 CI = Confidence Interval\n\n\n\n\n\n\n\n\n\n\nInflation Adjusted Total Charge:\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nCharacteristic\nBeta\n95% CI1\np-value\n\n\n\n\nRace\n\n\n\n\n\n\n\n\n    White\n—\n—\n\n\n\n\n    Asian or Pacific Islander\n33,604\n8,468, 58,739\n0.009\n\n\n    Black\n29,893\n18,331, 41,455\n&lt;0.001\n\n\n    Hispanic\n49,197\n34,222, 64,172\n&lt;0.001\n\n\n    Native American\n-38,986\n-66,502, -11,470\n0.006\n\n\n    Other\n46,036\n21,142, 70,931\n&lt;0.001\n\n\nAge, y\n322\n-72, 715\n0.11\n\n\nResidential income\n\n\n\n\n\n\n\n\n    $1 - $51,999\n—\n—\n\n\n\n\n    $52,000 - $65,999\n-686\n-8,417, 7,044\n0.9\n\n\n    $66,000 - $87,999\n-4,866\n-13,567, 3,834\n0.3\n\n\n    $88,000 or more\n5,674\n-7,256, 18,604\n0.4\n\n\nExpected primary payer\n\n\n\n\n\n\n\n\n    Private\n—\n—\n\n\n\n\n    Medicaid\n15,008\n3,806, 26,210\n0.009\n\n\n    Medicare\n9,819\n2,035, 17,602\n0.013\n\n\n    Other\n1,905\n-16,271, 20,081\n0.8\n\n\nHospital region\n\n\n\n\n\n\n\n\n    Midwest\n—\n—\n\n\n\n\n    Northeast\n-27,439\n-47,892, -6,986\n0.009\n\n\n    South\n36,214\n20,832, 51,596\n&lt;0.001\n\n\n    West\n159,147\n131,850, 186,444\n&lt;0.001\n\n\nHOSP_DIVISION\n\n\n\n\n\n\n\n\n    East North Central\n—\n—\n\n\n\n\n    East South Central\n-22,793\n-51,194, 5,608\n0.12\n\n\n    Middle Atlantic\n83,886\n57,864, 109,909\n&lt;0.001\n\n\n    Mountain\n-68,127\n-104,367, -31,886\n&lt;0.001\n\n\n    South Atlantic\n14,022\n-4,082, 32,126\n0.13\n\n\n    West North Central\n-13,723\n-27,097, -349\n0.044\n\n\nHospital bedsize\n\n\n\n\n\n\n\n\n    Large\n—\n—\n\n\n\n\n    Medium\n6,763\n-6,729, 20,256\n0.3\n\n\n    Small\n6,841\n-9,860, 23,543\n0.4\n\n\nHospital location and teaching status\n\n\n\n\n\n\n\n\n    Rural\n—\n—\n\n\n\n\n    Urban, non-teaching\n36,779\n12,947, 60,612\n0.003\n\n\n    Urban, teaching\n28,663\n8,370, 48,955\n0.006\n\n\nHypertension\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n-33,893\n-46,562, -21,224\n&lt;0.001\n\n\nDiabetes mellitus\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n-30,226\n-38,018, -22,433\n&lt;0.001\n\n\nCoronary artery disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n-191,335\n-224,621, -158,049\n&lt;0.001\n\n\nHeart failure\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n58,688\n50,607, 66,768\n&lt;0.001\n\n\nChronic kidney disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n-7,225\n-19,972, 5,523\n0.3\n\n\nChronic obstructive pulmonary disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n-7,482\n-15,826, 862\n0.079\n\n\nPeripheral vascular disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n-6,048\n-15,760, 3,665\n0.2\n\n\nLiver disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n110,185\n87,085, 133,284\n&lt;0.001\n\n\nFluid/electrolytes imbalance\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n64,662\n58,016, 71,307\n&lt;0.001\n\n\nAnemia\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n12,642\n-1,247, 26,530\n0.074\n\n\nObesity\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n-3,733\n-9,218, 1,752\n0.2\n\n\nTobbacco use disorder\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n-12,332\n-36,869, 12,205\n0.3\n\n\nPrior PCI\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n-7,288\n-13,208, -1,369\n0.016\n\n\nPrior myocardial inafarction\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n-41,744\n-48,570, -34,917\n&lt;0.001\n\n\nPrior stroke\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n-3,252\n-11,941, 5,438\n0.5\n\n\nPrior cardiac surgery\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n38,353\n20,729, 55,978\n&lt;0.001\n\n\nCharlson comorbidity index\n16,384\n12,326, 20,442\n&lt;0.001\n\n\n\n1 CI = Confidence Interval"
  }
]